Mar 27, 2026Fujifilm’s $8B investment at work in 2026 | Thermo Fisher’s Ridgefield, NJ expansion

Mar 26, 2026UCB plans $2B US manufacturing hub in Georgia | Evotec wins up to $10M BARDA contract

Mar 25, 2026WuXi AppTec’s US revenue grows over $34% | Novartis plans $480M expansion in China

Mar 24, 2026APIIC looks to strengthen US pharma supply chain | Esteve expands spray drying capacity

Mar 21, 2026AstraZeneca details $15B China investment | Celltrion ramps up CDMO business

Mar 20, 2026US dangerously dependent on China for APIs, KSMs | TerraPower plans ac-225 manufacturing facility

Mar 19, 2026Fujifilm clones Denmark facility in North Carolina | Axplora boosts high potency API capacity

Mar 18, 2026Lifecore’s weak near-term outlook | Almac launches flow hydrogenation capability

Mar 17, 2026FDA slaps Simtra with warning letter | Lilly, Samsung Biologics team on labs in Korea

Mar 14, 2026Blockbuster drug contenders on the horizon | Fujifilm boosts CDMO capabilities for ADCs

Mar 13, 2026ElevateBio to bring CGT manufacturing to Pittsburgh | Catalent teams on cell therapies

Mar 12, 2026Novo Nordisk hit with another FDA warning letter | Eli Lilly commits $3B in China

Mar 11, 2026Novo Nordisk’s troubles with former Catalent site continue | CSL’s $1.5B Illinois investment

Mar 10, 2026Lonza on path to being pure-play CDMO | Norgine’s $30M investment in Wales site

Mar 7, 2026Big Pharma, CDMOs seize GLP-1 opportunity | Upperton seeks MHRA approval for sterile site

Mar 6, 2026Stevanato’s GLP-1 business is on the rise | Forma Life Sciences launches CDMO

Mar 5, 2026Eli Lilly’s construction challenges | CordenPharma’s peptide development lab expansion

Mar 4, 2026Basel emerges as life sciences supercluster | Fujifilm launches precision purification tech

Mar 3, 2026Novo Nordisk invests $500M in Ireland plant expansion | WuXi XDC touts potential $885M ADC deal

Feb 28, 2026Q&A: WuXi Biologics CEO | Ipsen, Quotient extend commercial manufacturing pact

Feb 27, 2026Agilent’s GLP-1 CDMO business grows | Novartis plans 5th US radioligand manufacturing plant

Feb 26, 2026Charles River sells CDMO business | Big Pharma’s US investment plans short on details

Feb 25, 2026IDT Biologika looks to double sales by 2028 | AbbVie to build API plants in Chicago

Feb 24, 2026SCOTUS strikes down Trump tariffs, what’s next for pharma? | Siegfried’s 2026 outlook

Feb 21, 2026US biomanufacturing requires jumpstart in race with China | Lonza boosts advanced synthesis offering

Latest Edition